Evidence map›Paper›PMID 31355228›Full record

ArticleAnnals of translational medicine2019

Prognostic significance of the

Yan Liu, Zhiheng Cheng, Qihui Li, Yifan Pang, Longzhen Cui, Tingting Qian, Liang Quan, Yifeng Dai, Yang Jiao, Zhihui Zhang and 3 more

Open access · diamondAbstract read
In one paragraph

Article in Annals of translational medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Expression and Prognostic Role of PANK1 in Glioma.Combinatorial chemistry & high throughput screening · 2024
    Article
  5. Article
  6. Article
  7. Translational cancer research · 2022
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The Pathophysiological Role of CoA.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 3 countries.

Yan LiuDepartment of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Zhiheng ChengDepartment of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Qihui LiDepartment of Hematology and Lymphoma Research Center, Peking University, Third Hospital, Beijing 100191, China.
Yifan PangDepartment of Medicine, William Beaumont Hospital, Royal Oak, MI 48073, USA.
Longzhen CuiTranslational Medicine Center, Huaihe Hospital of Henan University, Kaifeng 475000, China.
Tingting QianDepartment of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Liang QuanDepartment of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Yifeng DaiImmunoendocrinology, Division of Medical Biology, Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Yang JiaoLife Sciences Institute and Innovation Center for Cell Signaling Network, Zhejiang University, Hangzhou 310058, China.
Zhihui ZhangDepartment of Stomatology, Peking University Third Hospital, Beijing 100191, China.
Xu YeDepartment of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Jinlong ShiDepartment of Medical Big Data, Chinese PLA General Hospital, Beijing 100853, China.
Lin FuDepartment of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Guangzhou Medical University · CNHenan University Huaihe Hospital and Huaihe Clinical Institute · CNPeking University · CNUniversity of Groningen · NLBeaumont Hospital, Royal Oak · USChinese PLA General Hospital · CNSecond Affiliated Hospital of Guangzhou Medical University · CNZhejiang University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAcute myeloid leukemia (AML) is a highly heterogenous hematological malignancy and its prognostication depends on the genetic mutation and expression profile of each patient. Pantothenate kinase (

methodsWe screened The Cancer Genome Atlas database for AML patients with complete

resultsPatients with high

conclusionsOur study suggested that high

Indexed as

Acute myeloid leukemia (AML)heterogeneitypantothenate kinase (PANK)prognosis

Identifiers

PMID31355228
PMCPMC6614324
OpenAlexW2946913288

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.